Next Science (ASX:NXS) Short-Term Capital Lease Obligation : A$0.41 Mil (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Next Science Short-Term Capital Lease Obligation?

Next Science's Short-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was A$0.41 Mil.

Next Science's quarterly Short-Term Capital Lease Obligation declined from Dec. 2022 (A$0.38 Mil) to Jun. 2023 (A$0.00 Mil) but then increased from Jun. 2023 (A$0.00 Mil) to Dec. 2023 (A$0.41 Mil).

Next Science's annual Short-Term Capital Lease Obligation increased from Dec. 2021 (A$0.23 Mil) to Dec. 2022 (A$0.38 Mil) and increased from Dec. 2022 (A$0.38 Mil) to Dec. 2023 (A$0.41 Mil).

Next Science Short-Term Capital Lease Obligation Historical Data

The historical data trend for Next Science's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Next Science Short-Term Capital Lease Obligation Chart

Next Science Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.29

0.23

0.38

0.41

Next Science Semi-Annual Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial					0.23	-	0.38	-	0.41

Next Science Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Next Science Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Next Science's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Next Science (ASX:NXS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Next Science Ltd (ASX:NXS) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

NXSCF:USA

Address

821 Pacific Highway, Suite 1902, Level 19, Tower A, The Zenith Building, Chatswood, NSW, AUS, 2067

Website

https://www.nextscience.com

Next Science Ltd is a medical technology company. It is engaged in the development and commercialization of its proprietary Xbio technology to reduce the impact of biofilm-based infections in human health. Xbio is a non-toxic technology with proven efficacy in eradicating both biofilm based and free-floating bacteria. Its products include Bactisure, SURGX, XEPERIENCE and BLASTX. The company derives revenue from the U.S. and Australia, of which prime revenue is derived from the U.S.

Next Science (ASX:NXS) Headlines

No Headlines